These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5378104)

  • 61. The treatment of hypertension. Why, when and how.
    Freis ED
    Am J Med; 1972 May; 52(5):664-71. PubMed ID: 4556935
    [No Abstract]   [Full Text] [Related]  

  • 62. The effect of hydrochlorothiazide on venous reactivity in hypertensive man.
    Ogilvie RI; Schlieper E
    Clin Pharmacol Ther; 1970; 11(4):589-94. PubMed ID: 5429183
    [No Abstract]   [Full Text] [Related]  

  • 63. Effect of treatment with hydrochlorothiazide on the red cell Na,K-adenosine triphosphatase in men with hypertension.
    Quintanilla AP; Finn M; Weffer MI; Del Greco F
    J Lab Clin Med; 1987 Nov; 110(5):583-7. PubMed ID: 2822824
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of adelphane and esidrex on the maximum daily dose of ismelin.
    Victor G
    J Assoc Physicians India; 1965 Nov; 13(11):851-8. PubMed ID: 5852368
    [No Abstract]   [Full Text] [Related]  

  • 65. Moderate sodium restriction and diuretics in the treatment of hypertension.
    Parijs J; Joossens JV; Van der Linden L; Verstreken G; Amery AK
    Am Heart J; 1973 Jan; 85(1):22-34. PubMed ID: 4564947
    [No Abstract]   [Full Text] [Related]  

  • 66. Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension.
    Araoye MA; Chang MY; Khatri IM; Freis ED
    JAMA; 1978 Oct; 240(17):1863-6. PubMed ID: 357764
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ; McNamee R; Carr M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Office management of hypertension.
    Grim CE
    Am Fam Physician; 1976 Jul; 14(1):91-4. PubMed ID: 937166
    [No Abstract]   [Full Text] [Related]  

  • 69. Comparison of debrisoquine and guanethidine in treatment of hypertension.
    Adi FC; Eze CJ; Anwunah A
    Br Med J; 1975 Mar; 1(5956):482-5. PubMed ID: 1125586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension].
    Glezer GA; Moskalenko NP
    Kardiologiia; 1972 Dec; 12(12):55-60. PubMed ID: 4661921
    [No Abstract]   [Full Text] [Related]  

  • 71. Practical office management of chronic hypertension.
    Raper AJ
    Va Med Mon (1918); 1974 Nov; 101(11):945-7. PubMed ID: 4428883
    [No Abstract]   [Full Text] [Related]  

  • 72. Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide.
    Leth A
    Circulation; 1970 Sep; 42(3):479-85. PubMed ID: 4988973
    [No Abstract]   [Full Text] [Related]  

  • 73. Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system.
    Jose A; Crout JR; Kaplan NM
    Ann Intern Med; 1970 Jan; 72(1):9-16. PubMed ID: 4312105
    [No Abstract]   [Full Text] [Related]  

  • 74. Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs.
    Limas CJ; Freis ED
    Am J Cardiol; 1973 Mar; 31(3):355-61. PubMed ID: 4687850
    [No Abstract]   [Full Text] [Related]  

  • 75. [Objectives and methods in therapy of essential arterial hypertension].
    Zanchetti A
    Cardiol Prat; 1968 Aug; 19(4):263-6. PubMed ID: 5746811
    [No Abstract]   [Full Text] [Related]  

  • 76. [Behavior of renin, aldosterone, electrolytes and extracellular spaces during combination diuretic therapy in hypertensive patients].
    Hilfenhaus M; Erbler HC; Mariss P; Liebau H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():299-302. PubMed ID: 611970
    [No Abstract]   [Full Text] [Related]  

  • 77. The effect of guanethidine and propranolol on capillary blood flow in subcutaneous tissue and muscle in essential hypertension.
    Pechan J; Ondrejicka M; Janotka M; Kellerová E
    Cardiology; 1974; 59(3):172-83. PubMed ID: 4447953
    [No Abstract]   [Full Text] [Related]  

  • 78. The influence of beta-blocking agents on plasma volume and extracellular volume in ischaemic heart disease.
    Hesse B; Bollerup AC; Olesen KH
    Scand J Clin Lab Invest; 1974 Nov; 34(3):215-7. PubMed ID: 4428163
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of hypertension with hydrochlorothiazide and spironolactone.
    Ogilvie RI; Ruedy J
    Can Med Assoc J; 1969 Nov; 101(10):61-4. PubMed ID: 5348877
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human serum dopamine- -hydroxylase. Relationship to hypertension and sympathetic activity.
    Horwitz D; Alexander RW; Lovenberg W; Keiser HR
    Circ Res; 1973 May; 32(5):594-9. PubMed ID: 4713201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.